The Europe peripheral vascular devices market is expected to grow from US$ 3,288.55 million in 2021 to US$ 5,035.19 million by 2028; it is estimated to register a CAGR of 6.3% from 2021 to 2028
The Europe peripheral vascular devices market is expected to grow from US$ 3,288.55 million in 2021 to US$ 5,035.19 million by 2028; it is estimated to register a CAGR of 6.3% from 2021 to 2028. The alarming rise in peripheral artery diseases has been a primary concern across the region. Atherosclerosis, smoking, alcoholism, and obesity are the major factors that increase the risk of developing these diseases. Further, atherosclerosis is a condition in which fatty deposits build up on the inside walls of the arteries, reducing blood flow. Healthy people over the age of 40 have a 50% chance of getting severe atherosclerosis, with the risk increasing as they get older. The disease mostly affects people over the age of 60, yet it goes unnoticed frequently. The increasing prevalence of atherosclerosis is boosting the peripheral vascular devices market substantially. As per the WHO, in 2021, ~1.13 billion people were suffering from hypertension, a leading cause of premature death. Obesity is associated with high blood pressure, dyslipidemia, diabetes or insulin resistance, and higher fibrinogen and C-reactive protein levels, which increase the risk of cardiovascular diseases.
The Europe Peripheral Vascular Devices Market is experiencing substantial growth due to the rising prevalence of peripheral artery disease, increasing aging population, and growing adoption of minimally invasive procedures. These devices play a critical role in diagnosing and treating diseases that affect blood vessels outside the heart and brain. As the population ages and the number of individuals with lifestyle-related diseases such as diabetes and hypertension increases, the demand for effective vascular interventions is also on the rise, boosting the Europe Peripheral Vascular Devices Market.
๐๐
๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ง๐ค @ https://www.businessmarketinsights.com/reports/europe-peripheral-vascular-devices-market
Technological advancements in medical devices have also significantly influenced the Europe Peripheral Vascular Devices Market. Innovations such as drug-coated balloons, bioresorbable stents, and advanced catheters are improving patient outcomes and reducing the need for repeat procedures. These cutting-edge technologies offer more precise and effective treatment options for peripheral vascular conditions, which has led to their increased adoption in clinical settings throughout Europe.
In addition, rising awareness among patients and healthcare providers about peripheral vascular diseases is contributing to the expansion of the Europe Peripheral Vascular Devices Market. Public health initiatives and educational campaigns are encouraging early diagnosis and treatment, which necessitates the use of peripheral vascular devices. As a result, there is an increasing demand for diagnostic and therapeutic devices across hospitals and specialized vascular centers.
Healthcare infrastructure in Europe is well-developed, with a strong emphasis on adopting advanced medical technologies. This, coupled with supportive government regulations and favorable reimbursement policies, has created a conducive environment for the Europe Peripheral Vascular Devices Market. Moreover, clinical research and trials conducted across European countries are fostering innovation and introducing new products into the market, further strengthening its position.
The surge in endovascular procedures is also playing a vital role in the growth of the Europe Peripheral Vascular Devices Market. These procedures are less invasive compared to traditional surgeries and offer faster recovery times, reduced hospital stays, and lower risks of complications. As patient preference shifts towards minimally invasive options, hospitals and clinics are increasingly investing in state-of-the-art peripheral vascular devices to meet this demand.
The COVID-19 pandemic had a temporary impact on the Europe Peripheral Vascular Devices Market, as elective procedures were postponed and healthcare resources were redirected towards emergency care. However, the market has rebounded strongly post-pandemic, with pent-up demand driving increased procedure volumes. This recovery highlights the resilience and long-term growth potential of the Europe Peripheral Vascular Devices Market.
Rising investments in healthcare technology and an increasing number of vascular specialists across Europe are further fueling market growth. These trends, combined with greater collaboration between research institutions and clinical centers, are accelerating the development of next-generation vascular solutions within the Europe Peripheral Vascular Devices Market. In summary, the Europe Peripheral Vascular Devices Market is on a strong upward trajectory, driven by demographic shifts, technological progress, and changing healthcare preferences. With ongoing innovations and a supportive regulatory landscape, the Europe Peripheral Vascular Devices Market is expected to maintain its growth momentum in the coming years.
๐๐ก๐ ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
Abbott
B. Braun Melsungen AG
BD
Boston Scientific Corporation
Cardinal Health Inc
Cook Medical LLC
Edwards Lifesciences Corporation
Medtronic
Teleflex Incorporated
Terumo Corporation
Europe Peripheral Vascular Devices Market Segmentation ย
ย The Europe peripheral vascular devices market is segmented into product, end user, and country. Based on product, the Europe peripheral vascular devices market is segmented into peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, and embolization guidewires. Further, the peripheral vascular stents segment dominated the market in 2021. Based on end user, the Europe peripheral vascular devices market is segmented into hospitals & clinics, ambulatory care centers, specialty clinics, and others. Further, the hospitals & clinics segment dominated the market in 2021. Based on country, the Europe peripheral vascular devices market is segmented into France, Germany, France, the UK, Italy, Spain, and the Rest of Europe. Further, Germany dominated the market in 2021.ย
Europe Peripheral Vascular Devices Strategic Insights
Strategic insights for the Europe Peripheral Vascular Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Obesity has emerged as another significant concern across Europe, with strong links to cardiovascular disease, including PAD. Excessive body weight is commonly associated with other health conditions such as hypertension, insulin resistance, diabetes, and elevated levels of inflammatory markers like fibrinogen and C-reactive protein. Each of these conditions independently contributes to vascular damage and dysfunction. The compounding effect of these comorbidities results in a higher likelihood of peripheral vascular complications, particularly among older adults. As obesity rates rise across various demographics, the demand for medical interventions, including peripheral vascular devices, is expected to increase proportionally.
Hypertension, or high blood pressure, is another major contributing factor to the growth of the peripheral vascular devices market. It is a leading cause of premature mortality and is particularly pervasive in developed regions such as Europe. Elevated blood pressure can damage the arteries over time, making them less elastic and more prone to plaque accumulation. This not only increases the risk of PAD but also exacerbates the impact of other cardiovascular conditions. The burden of hypertension in Europe is substantial, with millions affected and many unaware of their condition due to the often asymptomatic nature of the disease. The growing emphasis on preventive care and early diagnosis is therefore fostering the adoption of peripheral vascular devices across the healthcare continuum.
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
You can see this-
North America Frozen Bakery Products Market- https://businessmarketresportsnews.blogspot.com/2025/04/north-america-frozen-bakery-products.html
North America N95 Masks Market- https://sites.google.com/view/bmi-395/home
North America Remote Patient Monitoring Market- https://postyourarticle.com/north-america-remote-patient-monitoring-market-drivers-opportunities-trends-and-forecasts-by-2028-2/